Skip to main content
. Author manuscript; available in PMC: 2010 Aug 2.
Published in final edited form as: J Am Geriatr Soc. 2009 Feb 24;57(4):641–646. doi: 10.1111/j.1532-5415.2009.02169.x

Table 2.

Hazard Ratios* for All-Cause Dementia and All-Cause Mortality

Undetectable Detectable Elevated
N (N = 80) (N = 81) p-value (N = 66) p-value
All-Cause Dementia

All Subjects †
  Model 1 227 1.0 1.1 (0.6 - 1.8) 0.848 1.1 (0.6 - 1.9) 0.811
  Model 2 212 1.0 1.2 (0.6 - 2.1) 0.629 1.0 (0.5 - 1.8) 0.916
Gender
    Men
  Model 1 86 1.0 0.9 (0.3 - 2.3) 0.777 0.9 (0.4 - 2.2) 0.812
  Model 2 78 1.0 0.7 (0.2 - 2.3) 0.581 0.7 (0.2 - 2.0) 0.523
    Women
  Model 1 141 1.0 1.1 (0.6 - 2.2) 0.734 1.2 (0.6 - 2.4) 0.654
  Model 2 134 1.0 1.4 (0.7 - 3.0) 0.360 1.2 (0.5 - 2.8) 0.652
APOE genotype
    APOE4-
  Model 1 182 1.0 0.9 (0.5 - 1.6) 0.656 0.9 (0.5 - 1.8) 0.864
  Model 2 167 1.0 1.0 (0.5 - 2.1) 0.903 0.9 (0.4 - 1.8) 0.711
    APOE4+
  Model 1 45 1.0 1.6 (0.5 - 4.9) 0.415 1.9 (0.5 - 6.5) 0.319
  Model 2 45 1.0 4.5 (0.9 - 23.3) 0.074 2.7 (0.6 - 12.2) 0.209

All-Cause Mortality

All Subjects †
  Model 1 227 1.0 1.7 (1.1 - 2.8) 0.025 1.4 (0.9 - 2.4) 0.187
  Model 2 212 1.0 1.7 (1.0 - 2.9) 0.042 1.3 (0.7 - 2.2) 0.384
Gender
    Men
  Model 1 86 1.0 1.4 (0.7 - 2.9) 0.311 1.0 (0.5 - 2.2) 0.952
  Model 2 78 1.0 1.5 (0.7 - 3.6) 0.331 0.9 (0.4 - 2.1) 0.720
    Women
  Model 1 141 1.0 2.1 (1.1 - 4.2) 0.034 2.1 (1.0 - 4.3) 0.050
  Model 2 134 1.0 2.1 (1.0 - 4.5) 0.057 1.7 (0.8 - 4.0) 0.192
APOE genotype
    APOE4-
  Model 1 182 1.0 1.7 (1.0 - 2.9) 0.055 1.3 (0.7 - 2.2) 0.419
  Model 2 167 1.0 1.6 (0.9 - 2.9) 0.106 1.1 (0.6 - 2.1) 0.700
    APOE4+
  Model 1 45 1.0 2.1 (0.7 - 6.5) 0.212 1.9 (0.5 - 7.2) 0.339
  Model 2 45 1.0 5.6 (1.0 - 30.7) 0.046 2.6 (0.4 - 18.7) 0.345
*

Hazard ratios (HR), 95% confidence intervals (CI), and p-values were computed using Cox regression. Model 1 was adjusted for age. Model 2 was adjusted for age, gender, education, apolipoprotein E4 (APOE4) status, and medical history of hypertension, coronary artery disease, congestive heart failure, and transient ischemic attack. The number of subjects (N) shown is the total number included in that analysis.

†

In all subjects, age was significant in both models, and history of CHF was significant in Model 2.